Manchester Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $365K | Sell |
12,803
-365
| -3% | -$9.7K | 0.06% | 94 |
|
|
2026
Q2 | $317K | Buy |
13,168
+365
| +3% | +$9.5K | 0.06% | 107 |
|
|
2026
Q1 | $360K | Buy |
+12,803
| New | +$341K | 0.07% | 98 |
|
|
2025
Q4 | – | Sell |
-12,128
| Closed | -$309K | – | 143 |
|
|
2025
Q3 | $309K | Sell |
12,128
-58
| -0.5% | -$1.43K | 0.06% | 103 |
|
|
2025
Q2 | $295K | Sell |
12,186
-650
| -5% | -$15.2K | 0.06% | 98 |
|
|
2025
Q1 | $325K | Hold |
12,836
| – | – | 0.07% | 91 |
|
|
2024
Q4 | $341K | Sell |
12,836
-1,188
| -8% | -$32.2K | 0.07% | 79 |
|
|
2024
Q3 | $406K | Sell |
14,024
-24
| -0.2% | -$700 | 0.09% | 67 |
|
|
2024
Q2 | $393K | Hold |
14,048
| – | – | 0.1% | 66 |
|
|
2024
Q1 | $390K | Hold |
14,048
| – | – | 0.1% | 62 |
|
|
2023
Q4 | $404K | Buy |
14,048
+5,212
| +59% | +$158K | 0.11% | 59 |
|
|
2023
Q3 | $293K | Sell |
8,836
-32
| -0.4% | -$1.13K | 0.09% | 66 |
|
|
2023
Q2 | $325K | Buy |
8,868
+1,850
| +26% | +$72K | 0.09% | 67 |
|
|
2023
Q1 | $286K | Sell |
7,018
-54
| -0.8% | -$2.33K | 0.08% | 69 |
|
|
2022
Q4 | $362K | Sell |
7,072
-626
| -8% | -$30K | 0.1% | 64 |
|
|
2022
Q3 | $337K | Sell |
7,698
-99
| -1% | -$4.81K | 0.1% | 64 |
|
|
2022
Q2 | $409K | Sell |
7,797
-564
| -7% | -$28.7K | 0.16% | 56 |
|
|
2022
Q1 | $433K | Sell |
8,361
-2,244
| -21% | -$116K | 0.16% | 57 |
|
|
2021
Q4 | $626K | Buy |
10,605
+702
| +7% | +$34.8K | 0.22% | 47 |
|
|
2021
Q3 | $426K | Sell |
9,903
-355
| -3% | -$15.7K | 0.16% | 54 |
|
|
2021
Q2 | $402K | Buy |
10,258
+50
| +0.5% | +$1.94K | 0.16% | 57 |
|
|
2021
Q1 | $370K | Buy |
10,208
+2,813
| +38% | +$100K | 0.17% | 48 |
|
|
2020
Q4 | $272K | Sell |
7,395
-157
| -2% | -$5.76K | 0.17% | 50 |
|
|
2020
Q3 | $263K | Hold |
7,552
| – | – | 0.2% | 42 |
|
|
2020
Q2 | $234K | Buy |
7,552
+1,558
| +26% | +$52.9K | 0.19% | 50 |
|
|
2020
Q1 | $186K | Sell |
5,994
-721
| -11% | -$24.6K | 0.14% | 57 |
|
|
2019
Q4 | $250K | Sell |
6,715
-250
| -4% | -$8.9K | 0.1% | 55 |
|
|
2019
Q3 | $237K | Sell |
6,965
-1,027
| -13% | -$37.3K | 0.1% | 53 |
|
|
2019
Q2 | $328K | Hold |
7,992
| – | – | 0.15% | 42 |
|
|
2019
Q1 | $322K | Hold |
7,992
| – | – | 0.16% | 44 |
|
|
2018
Q4 | $331K | Buy |
+7,992
| New | +$332K | 0.18% | 41 |
|
Other funds holding PFE
Manchester Financial's PFE Position: Q3 2026 in Review
Manchester Financial reduced its Pfizer (PFE) stake by 2.8% in Q3 2026, selling an estimated $9.7K and leaving 12,803 shares worth $365K. The position accounts for 0.06% of the portfolio, ranked #94.
Manchester Financial first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $626K in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Manchester Financial held 12,803 shares of Pfizer worth $365K as of Q3 2026.
- Manchester Financial sold 365 Pfizer shares in Q3 2026, an estimated $9.7K.
- Pfizer made up 0.06% of Manchester Financial's portfolio in Q3 2026, its #94 holding.
- Manchester Financial first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Manchester Financial's Pfizer position peaked at $626K in Q4 2021.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Manchester Financial's 13F filing for Q3 2026, filed 15 Oct 2026.